marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2023
added 03-22-2024
Recro Pharma Income Statement 2011-2024 | REPH
Annual Income Statement Recro Pharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
133 M | 81 M | 61.8 M | 33.2 M | 371 M | 145 M | 149 M | 69.3 M | 59.6 M | 17.1 M | - | - | - |
Shares |
95.2 M | 57.9 M | 44.1 M | 23.7 M | 22.4 M | 20.5 M | 19.1 M | 10.7 M | 8.49 M | 6.24 M | - | - | - |
Historical Prices |
1.4 | 1.4 | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-13.3 M | -19.9 M | -11.4 M | -27.5 M | -18.6 M | -79.7 M | -50.1 M | -30.2 M | 3.03 M | -16.1 M | -1.96 M | -1.54 M | -2.87 M |
Revenue |
94.6 M | 90.2 M | 75.4 M | 66.5 M | 99.2 M | 77.3 M | 71.8 M | 69.3 M | 52 M | - | - | - | - |
Cost of Revenue |
76.5 M | 67.1 M | 55.5 M | 54.1 M | 51 M | 43.2 M | 38.2 M | 37.2 M | 28.1 M | - | - | - | - |
Gross Profit |
- | - | - | - | 48.2 M | 34.2 M | 33.6 M | 32.2 M | 23.9 M | - | - | - | - |
Operating Income |
-3.57 M | 279 K | 412 K | -8.34 M | 23.6 M | 12.5 M | -40.3 M | -25.8 M | -6.97 M | -11.9 M | - | - | - |
Interest Expense |
9.96 M | 14.2 M | 15.1 M | 19.2 M | 19 M | 8.11 M | 12 M | 5.59 M | 5.56 M | 4.27 M | 868 K | - | - |
EBITDA |
4.65 M | 7.69 M | 6.94 M | -2.38 M | 28.3 M | -42.7 M | -24.9 M | -13.8 M | -1.4 M | -11.9 M | -1.09 M | -794 K | -2.31 M |
Operating Expenses |
- | - | - | - | 22.5 M | 79.4 M | 61.1 M | 48.6 M | 27.2 M | 11.9 M | 1.09 M | - | - |
General and Administrative Expenses |
21 M | 22 M | 18.4 M | 18.1 M | - | 36.9 M | 25.4 M | 12.7 M | 13 M | 4 M | 546 K | 339 K | 485 K |
All numbers in USD currency
Quarterly Income Statement Recro Pharma
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
101 M | 87.3 M | 84.8 M | 84.6 M | 56.7 M | 56.6 M | 56.4 M | 46.7 M | 51.4 M | 39 M | 29.7 M | 28.6 M | 23.6 M | 23.6 M | 23.4 M | 23.3 M | 22.5 M | 22.3 M | 21.9 M | 21.8 M | 20.7 M | 20.4 M | 19.2 M | 19.1 M | 19.1 M | 19.1 M | 19 M | 19 M | 10.8 M | 9.54 M | 9.25 M | 9.22 M | 9.12 M | 7.83 M | 7.77 M | 7.71 M | 7.71 M | 7.71 M | 1.75 M | 156 K | 156 K | 156 K | 156 K | - | - | - | - | - | - | - | - |
Net Income |
-4.59 M | -3.21 M | -4.68 M | - | -3.33 M | -3.12 M | -4.26 M | - | -3.49 M | 1.23 M | -6.76 M | - | -2.13 M | -6.01 M | -7.69 M | - | -4.3 M | -2.84 M | -1.98 M | - | -13.3 M | -12.7 M | -12.5 M | - | -9.06 M | -8.86 M | -8.09 M | - | -5.38 M | -7.88 M | -6.54 M | - | -2.15 M | -1.31 M | -4.14 M | - | -4.71 M | -2.79 M | -5.15 M | - | -504 K | -661 K | -409 K | - | - | - | - | - | - | - | - |
Revenue |
23.6 M | 21.8 M | 21.5 M | - | 21.6 M | 23.2 M | 21.2 M | - | 18.2 M | 18 M | 16.8 M | - | 19.3 M | 15.5 M | 21.8 M | - | 25.3 M | 31.3 M | 25.1 M | - | 18.3 M | 21.7 M | 19.5 M | - | 17.1 M | 16.9 M | 18.7 M | - | 17 M | 17.3 M | 17.7 M | - | 16.5 M | 18.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
19.9 M | 17.3 M | 19.3 M | - | 16.1 M | 17.5 M | 16.1 M | - | 13.2 M | 12.3 M | 14.3 M | - | 11.7 M | 11.6 M | 18.3 M | - | 11 M | 14.1 M | 14.4 M | - | 8.47 M | 12.1 M | 10.5 M | - | 6.88 M | 10.4 M | 10.5 M | - | 5.74 M | 9.55 M | 10.3 M | - | 10 M | 9.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-1.76 M | -968 K | -2.6 M | - | 215 K | 302 K | -851 K | - | 336 K | 1.84 M | -2.86 M | - | 2.48 M | -1.02 M | -2.57 M | - | 9.43 M | 9.94 M | 3.79 M | - | -13.6 M | -13.3 M | -12.8 M | - | -10.7 M | -9.43 M | -7.3 M | - | -3.92 M | -6.77 M | -5.02 M | - | -164 K | 373 K | -4.14 M | - | -4.72 M | -2.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
2.91 M | 2.31 M | 2.14 M | - | 3.59 M | 3.43 M | 3.42 M | - | 3.82 M | 3.96 M | 3.9 M | - | 4.61 M | 5 M | 5.12 M | - | 5.06 M | 5.18 M | 3.76 M | - | 2.2 M | 2.19 M | 2.1 M | - | 1.24 M | 1.21 M | 1.18 M | - | 1.45 M | 1.32 M | 1.51 M | - | 1.99 M | 1.69 M | - | - | 4.27 M | 4.27 M | 4.27 M | - | 221 K | 213 K | 203 K | - | - | - | - | - | - | - | - |
EBITDA |
-1.59 M | -800 K | -693 K | - | 459 K | 522 K | 941 K | - | 5.14 M | 4.88 M | -1.43 M | - | 4.06 M | 491 K | -1.07 M | - | 11.7 M | 12.2 M | 5.87 M | - | -11.6 M | -11.4 M | -11 M | - | -8.83 M | -7.56 M | -5.46 M | - | -2.03 M | -4.85 M | -3.11 M | - | 1.28 M | 1.64 M | -4.14 M | - | -4.72 M | -2.8 M | - | - | 1.33 K | 969 | 485 | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.14 M | - | 4.72 M | 2.8 M | 874 K | - | 283 K | 449 K | 206 K | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
5.31 M | 5.27 M | 4.66 M | - | 5.08 M | 5.16 M | 5.71 M | - | 4.61 M | 3.79 M | 4.68 M | - | 4.42 M | 4.26 M | 5.45 M | - | 6.88 M | 10 M | 14.2 M | - | 6.97 M | 13 M | 9.52 M | - | 6.64 M | 6.32 M | 4.03 M | - | 3.84 M | 2.76 M | 2.66 M | - | 3.48 M | 2.6 M | 2.39 M | - | 1.08 M | 959 K | 647 K | - | 161 K | 204 K | 91.7 K | - | - | - | - | - | - | - | - |
All numbers in USD currency